Osteoblend
Osteoblend, licence 80063181: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Osteo Symmetry
- Licence holder
- Vitanica
- NPN or DIN-HM
- 80063181
- Status
- Active licence
- Licence date
- 6 August 2015
- Revision date
- 28 September 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 8 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 200.0 milligramme | Not calculated |
| Bore Source : Boron | 1.5 milligramme | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 750.0 microgrammes | Not calculated |
| Silicium Source : Silicium | 50.0 microgrammes | Not calculated |
| Vitamine D Source : Ergocalciférol | 400.0 Unités internationales | Not calculated |
| Vitamine D Source : Ergocalciférol | 10.0 microgrammes | Not calculated |
| Vitamine K1 Source : Vitamine K1 | 100.0 microgrammes | Not calculated |
| Riboflavine Source : Riboflavin 5'-phosphate de sodium | 10.0 milligramme | 10,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxal | 10.0 milligramme | 10,000 µg |
| Calcium Source : Citrate de calcium | 300.0 milligramme | 300,000 µg |
| Calcium Source : Carbonate de calcium | 300.0 milligramme | 300,000 µg |
| Calcium Source : Malate de calcium | 300.0 milligramme | 300,000 µg |
| Magnésium Source : Citrate de magnésium | 150.0 milligramme | 150,000 µg |
| Zinc Source : Picolinate de zinc | 13.0 milligramme | 13,000 µg |
| Sélénium Source : Selemethionine | 50.0 microgrammes | Not calculated |
| Manganèse Source : Citrate de manganèse (II) | 8.0 milligramme | 8,000 µg |
Non-medicinal ingredients
Cellulose, Hypromellose, L-Leucine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have a liver disorder or are taking blood thinners.
Source
Official Health Canada record, licence 80063181
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.